{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:06:29Z","timestamp":1786979189490,"version":"build-2736575974"},"publisher-location":"Singapore","reference-count":172,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811055614","type":"print"},{"value":"9789811055621","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-5562-1_9","type":"book-chapter","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T04:59:07Z","timestamp":1509598747000},"page":"169-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biochemical Diagnosis in Substance and Non-substance Addiction"],"prefix":"10.1007","author":[{"given":"Wenwen","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","volume":"83","author":"KE Moeller","year":"2008","unstructured":"Moeller KE, Lee KC, Kissack JC (2008) Urine drug screening: practical guide for clinicians. Mayo Clin Proc 83:66\u201376","journal-title":"Mayo Clin Proc"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/alcalc\/agg052","volume":"38","author":"K Junghanns","year":"2003","unstructured":"Junghanns K et al (2003) Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol Oxf Oxfs 38:189\u2013193","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00213-011-2414-1","volume":"218","author":"D Meng","year":"2011","unstructured":"Meng D et al (2011) Serum NPY and BNDF response to a behavioral stressor in alcohol-dependent and healthy control participants. Psychopharmacology (Berl.) 218:59\u201367","journal-title":"Psychopharmacology (Berl.)"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000346110","volume":"67","author":"A Glahn","year":"2013","unstructured":"Glahn A et al (2013) Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients. Neuropsychobiology 67:111\u2013115","journal-title":"Neuropsychobiology"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.psychres.2014.11.078","volume":"226","author":"O Geisel","year":"2015","unstructured":"Geisel O, Panneck P, Hellweg R, Wiedemann K, M\u00fcller CA (2015) Hypothalamic-pituitary-adrenal axis activity in patients with pathological gambling and internet use disorder. Psychiatry Res 226:97\u2013102","journal-title":"Psychiatry Res"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/alcalc\/37.4.401","volume":"37","author":"F Kiefer","year":"2002","unstructured":"Kiefer F, Jahn H, Schick M, Wiedemann K (2002) Alcohol intake, tumour necrosis factor-\u03b1, l eptin and craving: factors of a possibly vicious circle? Alcohol Alcohol 37:401\u2013404","journal-title":"Alcohol Alcohol"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archgenpsychiatry.2011.49","volume":"68","author":"R Sinha","year":"2011","unstructured":"Sinha R et al (2011) Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry 68:942\u2013952","journal-title":"Arch Gen Psychiatry"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.63.3.324","volume":"63","author":"R Sinha","year":"2006","unstructured":"Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324\u2013331","journal-title":"Arch Gen Psychiatry"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(00)01302-8","volume":"470","author":"T Nakahashi","year":"2000","unstructured":"Nakahashi T et al (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113\u2013117","journal-title":"FEBS Lett"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.psychres.2010.07.028","volume":"186","author":"S-W Choi","year":"2011","unstructured":"Choi S-W, Bhang S, Ahn J-H (2011) Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects. Psychiatry Res 186:427\u2013430","journal-title":"Psychiatry Res"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.pnpbp.2010.05.025","volume":"34","author":"A Heberlein","year":"2010","unstructured":"Heberlein A et al (2010a) BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 34:1060\u20131064","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1530-0277.2010.01329.x","volume":"35","author":"M-C Huang","year":"2011","unstructured":"Huang M-C et al (2011) Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin Exp Res 35:126\u2013131","journal-title":"Alcohol Clin Exp Res"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1177\/0269881111411332","volume":"25","author":"A Heberlein","year":"2011","unstructured":"Heberlein A et al (2011a) Serum levels of BDNF are associated with craving in opiate-dependent patients. J Psychopharmacol Oxf Engl 25:1480\u20131484","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2014.04.048","volume":"571","author":"J Zhang","year":"2014","unstructured":"Zhang J et\u00a0al (2014) Increased serum brain-derived neurotrophic factor levels during opiate withdrawal. Neurosci Lett 571:61\u201365","journal-title":"Neurosci Lett"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/0269881107078491","volume":"21","author":"F Angelucci","year":"2007","unstructured":"Angelucci F et al (2007) Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol Oxf Engl 21:820\u2013825","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1369-1600.2012.00444.x","volume":"19","author":"P-H Chen","year":"2014","unstructured":"Chen P-H, Huang M-C, Lai Y-C, Chen P-Y, Liu H-C (2014) Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal. Addict Biol 19:482\u2013485","journal-title":"Addict Biol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.euroneuro.2012.08.016","volume":"23","author":"M Corominas-Roso","year":"2013","unstructured":"Corominas-Roso M et al (2013) Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 23:1078\u20131084","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2011.05.013","volume":"70","author":"C D\u2019Sa","year":"2011","unstructured":"D\u2019Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R (2011) Increased serum brain-derived neurotrophic factor (BDNF) is predictive of cocaine relapse outcomes: A prospective study. Biol Psychiatry 70:706\u2013711","journal-title":"Biol Psychiatry"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"e2604","DOI":"10.1097\/MD.0000000000002604","volume":"95","author":"W Ren","year":"2016","unstructured":"Ren W et al (2016) Time-dependent serum brain-derived neurotrophic factor decline during methamphetamine withdrawal. Medicine (Baltimore) 95:e2604","journal-title":"Medicine (Baltimore)"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000338281","volume":"18","author":"O Geisel","year":"2012","unstructured":"Geisel O, Banas R, Hellweg R, M\u00fcller CA (2012) Altered serum levels of brain-derived neurotrophic factor in patients with pathological gambling. Eur Addict Res 18:297\u2013301","journal-title":"Eur Addict Res"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.psychres.2012.12.020","volume":"209","author":"O Geisel","year":"2013","unstructured":"Geisel O, Banas R, Schneider M, Hellweg R, M\u00fcller CA (2013) Serum levels of brain-derived neurotrophic factor in patients with internet use disorder. Psychiatry Res 209:525\u2013528","journal-title":"Psychiatry Res"},{"key":"9_CR22","first-page":"357","volume":"7","author":"C Hilburn","year":"2011","unstructured":"Hilburn C et al (2011) Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine? Neuropsychiatr Dis Treat 7:357\u2013364","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-2009-1146","volume":"18","author":"G Straten","year":"2009","unstructured":"Straten G, Eschweiler GW, Maetzler W, Laske C, Leyhe T (2009) Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer\u2019s disease and normal controls. J Alzheimers Dis JAD 18:331\u2013337","journal-title":"J Alzheimers Dis JAD"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00406-010-0121-2","volume":"261","author":"D Wedekind","year":"2011","unstructured":"Wedekind D et al (2011) S100B and homocysteine in the acute alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci 261:133\u2013138","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.pnpbp.2010.12.021","volume":"35","author":"A Heberlein","year":"2011","unstructured":"Heberlein A et al (2011b) Decreased galanin serum levels are associated with alcohol-craving during withdrawal. Prog Neuro-Psychopharmacol Biol Psychiatry 35:568\u2013572","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4933-4-6","volume":"4","author":"AS Reece","year":"2007","unstructured":"Reece AS (2007) Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immun Ageing A 4:6","journal-title":"Immun Ageing A"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13556210410001674068","volume":"9","author":"SKN Islam","year":"2004","unstructured":"Islam SKN, Hossain KJ, Kamal M, Ahsan M (2004) Serum immunoglobulins and white blood cells status of drug addicts: influence of illicit drugs and sex habit. Addict Biol 9:27\u201333","journal-title":"Addict Biol"},{"key":"9_CR28","first-page":"210","volume":"18","author":"A Azarang","year":"2007","unstructured":"Azarang A et al (2007) T-helper 1 and 2 serum cytokine assay in chronic opioid addicts. Eur Cytokine Netw 18:210\u2013214","journal-title":"Eur Cytokine Netw"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2012.07.026","volume":"525","author":"W-L Shi","year":"2012","unstructured":"Shi W-L et al (2012) Serum proteomics of methamphetamine addicts and up-regulation of complement factor H related to methamphetamine addiction. Neurosci Lett 525:23\u201328","journal-title":"Neurosci Lett"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11481-009-9185-z","volume":"5","author":"RN Achur","year":"2010","unstructured":"Achur RN, Freeman WM, Vrana KE (2010) Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 5:83\u201391","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.alcohol.2014.08.003","volume":"48","author":"A Heberlein","year":"2014","unstructured":"Heberlein A et al (2014) TNF-\u03b1 and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients? Alcohol Fayettev N 48:671\u2013676","journal-title":"Alcohol Fayettev N"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cyto.b.20169","volume":"72","author":"FJ Laso","year":"2007","unstructured":"Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A (2007) Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom 72:408\u2013415","journal-title":"Cytometry B Clin Cytom"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.alcohol.2004.02.004","volume":"32","author":"C Nicolaou","year":"2004","unstructured":"Nicolaou C et al (2004) Serum cytokine concentrations in alcohol-dependent individuals without liver disease. Alcohol Fayettev N 32:243\u2013247","journal-title":"Alcohol Fayettev N"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/alcalc\/35.4.351","volume":"35","author":"S Bleich","year":"2000","unstructured":"Bleich S et al (2000) Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol Oxf Oxfs 35:351\u2013354","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/alcalc\/ags058","volume":"47","author":"P Heese","year":"2012","unstructured":"Heese P et al (2012) Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: results from the German Investigation on Neurobiology in Alcoholism (GINA). Alcohol Alcohol Oxf Oxfs 47:497\u2013500","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"9_CR36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.euroneuro.2012.03.010","volume":"22","author":"H Frieling","year":"2012","unstructured":"Frieling H et al (2012) Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 22:836\u2013840","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1369-1600.2010.00215.x","volume":"15","author":"A Heberlein","year":"2010","unstructured":"Heberlein A et al (2010b) Serum levels of vascular endothelial growth factor A increase during alcohol withdrawal. Addict Biol 15:362\u2013364","journal-title":"Addict Biol"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000337212","volume":"18","author":"A Heberlein","year":"2012","unstructured":"Heberlein A et al (2012) Association of nerve growth factor and vascular endothelial growth factor A with psychometric measurements of opiate dependence: results of a pilot study in patients participating in a structured diamorphine maintenance program. Eur Addict Res 18:213\u2013219","journal-title":"Eur Addict Res"},{"key":"9_CR39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.PSY.0000039754.23250.EE","volume":"65","author":"L Buydens-Branchey","year":"2003","unstructured":"Buydens-Branchey L, Branchey M (2003) Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom Med 65:86\u201391","journal-title":"Psychosom Med"},{"key":"9_CR40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e318262a9a1","volume":"6","author":"S-H Lin","year":"2012","unstructured":"Lin S-H et al (2012) Association between cholesterol plasma levels and craving among heroin users. J Addict Med 6:287\u2013291","journal-title":"J Addict Med"},{"key":"9_CR41","first-page":"73","volume":"54","author":"J Housov\u00e1","year":"2005","unstructured":"Housov\u00e1 J et\u00a0al (2005) Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res Acad Sci Bohemoslov 54:73\u201378","journal-title":"Physiol Res Acad Sci Bohemoslov"},{"key":"9_CR42","first-page":"916","volume":"12","author":"B Shahouzehi","year":"2013","unstructured":"Shahouzehi B, Shokoohi M, Najafipour H (2013) The effect of opium addiction on serum adiponectin and leptin levels in male subjects: a case control study from Kerman coronary artery disease risk factors study (KERCADRS). EXCLI J 12:916\u2013923","journal-title":"EXCLI J"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.ALC.0000164360.43907.24","volume":"29","author":"D B\u00f6nsch","year":"2005","unstructured":"B\u00f6nsch D et al (2005) Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving. Alcohol Clin Exp Res 29:763\u2013765","journal-title":"Alcohol Clin Exp Res"},{"key":"9_CR44","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4161\/auto.25468","volume":"9","author":"Y-M Feng","year":"2013","unstructured":"Feng Y-M et al (2013) Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin. Autophagy 9:1395\u20131406","journal-title":"Autophagy"},{"key":"9_CR45","first-page":"18","volume":"34","author":"A Reece","year":"2013","unstructured":"Reece A, Elevated S (2013) IGF1 in clinical opiate dependence. Neuro Endocrinol Lett 34:18\u201326","journal-title":"Neuro Endocrinol Lett"},{"key":"9_CR46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00213-004-1856-0","volume":"176","author":"AA Patkar","year":"2004","unstructured":"Patkar AA et al (2004) Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. Psychopharmacology (Berl.) 176:74\u201381","journal-title":"Psychopharmacology (Berl.)"},{"key":"9_CR47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/genes6040991","volume":"6","author":"AM Andersen","year":"2015","unstructured":"Andersen AM, Dogan MV, Beach SRH, Philibert RA (2015) Current and future prospects for epigenetic biomarkers of substance use disorders. Genes 6:991\u20131022","journal-title":"Genes"},{"key":"9_CR48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/npp.2008.108","volume":"34","author":"DA Nielsen","year":"2009","unstructured":"Nielsen DA et al (2009) Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 34:867\u2013873","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"9_CR49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00439-010-0807-6","volume":"127","author":"DA Nielsen","year":"2010","unstructured":"Nielsen DA et al (2010) Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet 127:639\u2013649","journal-title":"Hum Genet"},{"key":"9_CR50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5055\/jom.2011.0067","volume":"7","author":"VM Chorbov","year":"2011","unstructured":"Chorbov VM, Todorov AA, Lynskey MT, Cicero TJ (2011) Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. J Opioid Manag 7:258\u2013264","journal-title":"J Opioid Manag"},{"key":"9_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000338642","volume":"19","author":"A Rotter","year":"2013","unstructured":"Rotter A et al (2013) CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence. Eur Addict Res 19:13\u201320","journal-title":"Eur Addict Res"},{"key":"9_CR52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gene.2016.03.010","volume":"584","author":"X Xu","year":"2016","unstructured":"Xu X et al (2016) A significant association between BDNF promoter methylation and the risk of drug addiction. Gene 584:54\u201359","journal-title":"Gene"},{"key":"9_CR53","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/ajmg.b.31109","volume":"153B","author":"M Toledo-Rodriguez","year":"2010","unstructured":"Toledo-Rodriguez M et al (2010) Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 153B:1350\u20131354","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR54","first-page":"1568","volume":"19","author":"Q Ge","year":"2014","unstructured":"Ge Q et al (2014) miRNA in plasma exosome is stable under different storage conditions. Mol Basel Switz 19:1568\u20131575","journal-title":"Mol Basel Switz"},{"key":"9_CR55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2016.01.028","volume":"615","author":"S Huang","year":"2016","unstructured":"Huang S et al (2016) Serum miR-132 is a risk marker of post-stroke cognitive impairment. Neurosci Lett 615:102\u2013106","journal-title":"Neurosci Lett"},{"key":"9_CR56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(11)70286-1","volume":"11","author":"E Salta","year":"2012","unstructured":"Salta E, De Strooper B (2012) Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol 11:189\u2013200","journal-title":"Lancet Neurol"},{"key":"9_CR57","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.0605781103","volume":"103","author":"H-J Lee","year":"2006","unstructured":"Lee H-J, Palkovits M, Young WS 3rd (2006) miR-7b, a microRNA up-regulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation. Proc Natl Acad Sci U S A 103:15669\u201315674","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR58","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1261\/rna.2775511","volume":"17","author":"JE Eipper-Mains","year":"2011","unstructured":"Eipper-Mains JE et al (2011) microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA N Y N 17:1529\u20131543","journal-title":"RNA N Y N"},{"key":"9_CR59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fgene.2012.00223","volume":"3","author":"RE Rodriguez","year":"2012","unstructured":"Rodriguez RE (2012) Morphine and microRNA activity: is there a relation with addiction? Front Genet 3:223","journal-title":"Front Genet"},{"key":"9_CR60","first-page":"1230","volume":"6","author":"X Wang","year":"2015","unstructured":"Wang X et al (2015) Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages. Front Microbiol 6:1230","journal-title":"Front Microbiol"},{"key":"9_CR61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11481-014-9577-6","volume":"10","author":"Y Zhou","year":"2015","unstructured":"Zhou Y et al (2015) Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 10:102\u2013110","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"9_CR62","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1038\/tp.2016.4","volume":"6","author":"X Long","year":"2016","unstructured":"Long X et al (2016) MiR-582-5p\/miR-590-5p targeted CREB1\/CREB5-NF-kappaB signaling and caused opioid-induced immunosuppression in human monocytes. Transl Psychiatry 6:e757","journal-title":"Transl Psychiatry"},{"key":"9_CR63","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","volume":"8","author":"MJ Kreek","year":"2005","unstructured":"Kreek MJ, Nielsen DA, Butelman ER, LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8:1450\u20131457","journal-title":"Nat Neurosci"},{"key":"9_CR64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s13181-012-0286-3","volume":"9","author":"AF Manini","year":"2013","unstructured":"Manini AF, Jacobs MM, Vlahov D, Hurd YL (2013) Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. J Med Toxicol Off J Am Coll Med Toxicol 9:148\u2013154","journal-title":"J Med Toxicol Off J Am Coll Med Toxicol"},{"key":"9_CR65","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1523\/JNEUROSCI.3986-13.2014","volume":"34","author":"J Xu","year":"2014","unstructured":"Xu J et\u00a0al (2014) A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the mu opioid receptor gene OPRM1 via hnRNPH interactions. J Neurosci 34:11048\u201311066","journal-title":"J Neurosci"},{"key":"9_CR66","first-page":"179","volume":"6","author":"S Ide","year":"2006","unstructured":"Ide S et al (2006) Linkage disequilibrium and association with methamphetamine dependence\/psychosis of mu-opioid receptor gene polymorphisms. Pharm J 6:179\u2013188","journal-title":"Pharm J"},{"key":"9_CR67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/1096-8628(20001009)96:5<592::AID-AJMG3>3.0.CO;2-Y","volume":"96","author":"BR Lawford","year":"2000","unstructured":"Lawford BR et al (2000) The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 96:592\u2013598","journal-title":"Am J Med Genet"},{"key":"9_CR68","doi-asserted-by":"crossref","first-page":"e66592","DOI":"10.1371\/journal.pone.0066592","volume":"8","author":"A Vereczkei","year":"2013","unstructured":"Vereczkei A et al (2013) Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One 8:e66592","journal-title":"PLoS One"},{"key":"9_CR69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008571-199606000-00004","volume":"6","author":"DE Comings","year":"1996","unstructured":"Comings DE et al (1996) A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 6:223\u2013234","journal-title":"Pharmacogenetics"},{"key":"9_CR70","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/0269881114551079","volume":"28","author":"AB Fagundo","year":"2014","unstructured":"Fagundo AB et al (2014) Dopamine DRD2\/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers. J Psychopharmacol Oxf Engl 28:1170\u20131177","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"9_CR71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biopsycho.2010.04.008","volume":"85","author":"DSS Lobo","year":"2010","unstructured":"Lobo DSS et al (2010) Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol 85:33\u201337","journal-title":"Biol Psychol"},{"key":"9_CR72","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1096-8628(20001009)96:5<599::AID-AJMG4>3.0.CO;2-O","volume":"96","author":"R Horowitz","year":"2000","unstructured":"Horowitz R et al (2000) Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet 96:599\u2013603","journal-title":"Am J Med Genet"},{"key":"9_CR73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajmg.b.30024","volume":"129B","author":"T Li","year":"2004","unstructured":"Li T et al (2004) Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 129B:120\u2013124","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR74","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ajmg.b.30716","volume":"147B","author":"BE Oosterhuis","year":"2008","unstructured":"Oosterhuis BE et al (2008) Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 147B:793\u2013798","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10899-013-9434-1","volume":"31","author":"CR Guillot","year":"2015","unstructured":"Guillot CR, Fanning JR, Liang T, Berman ME (2015) COMT associations with disordered gambling and drinking measures. J Gambl Stud 31:513\u2013524","journal-title":"J Gambl Stud"},{"key":"9_CR76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/hmg\/ddl441","volume":"16","author":"LJ Bierut","year":"2007","unstructured":"Bierut LJ et al (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16:24\u201335","journal-title":"Hum Mol Genet"},{"key":"9_CR77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2010.07.005","volume":"30","author":"SM Hartz","year":"2010","unstructured":"Hartz SM, Bierut LJ (2010) Genetics of addictions. Clin Lab Med 30:847\u2013864","journal-title":"Clin Lab Med"},{"key":"9_CR78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000444755","volume":"2","author":"KP Jensen","year":"2016","unstructured":"Jensen KP (2016) A review of genome-wide association studies of stimulant and opioid use disorders. Mol Neuropsychiatry 2:37\u201345","journal-title":"Mol Neuropsychiatry"},{"key":"9_CR79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/hmg\/ddl438","volume":"16","author":"SF Saccone","year":"2007","unstructured":"Saccone SF et al (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16:36\u201349","journal-title":"Hum Mol Genet"},{"key":"9_CR80","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.mp.4002154","volume":"13","author":"W Berrettini","year":"2008","unstructured":"Berrettini W et al (2008) Alpha-5\/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13:368\u2013373","journal-title":"Mol Psychiatry"},{"key":"9_CR81","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-09-0786","volume":"69","author":"NL Saccone","year":"2009","unstructured":"Saccone NL et al (2009) The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 69:6848\u20136856","journal-title":"Cancer Res"},{"key":"9_CR82","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/jnci\/djn363","volume":"100","author":"MR Spitz","year":"2008","unstructured":"Spitz MR, Amos CI, Dong Q, Lin J, Wu X (2008) The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100:1552\u20131556","journal-title":"J Natl Cancer Inst"},{"key":"9_CR83","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature06846","volume":"452","author":"TE Thorgeirsson","year":"2008","unstructured":"Thorgeirsson TE et al (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638\u2013642","journal-title":"Nature"},{"key":"9_CR84","doi-asserted-by":"crossref","first-page":"e1000125","DOI":"10.1371\/journal.pgen.1000125","volume":"4","author":"RB Weiss","year":"2008","unstructured":"Weiss RB et al (2008) A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 4:e1000125","journal-title":"PLoS Genet"},{"key":"9_CR85","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1038\/npp.2015.131","volume":"40","author":"KP Jensen","year":"2015","unstructured":"Jensen KP et al (2015) A CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 40:2813\u20132821","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"9_CR86","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1073\/pnas.0911998107","volume":"107","author":"Y Liu","year":"2010","unstructured":"Liu Y et al (2010a) Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species. Proc Natl Acad Sci U S A 107:1217\u20131222","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR87","doi-asserted-by":"crossref","unstructured":"Saccone NL et al (2010) Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet 6","DOI":"10.1371\/journal.pgen.1001053"},{"key":"9_CR88","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng.573","volume":"42","author":"TE Thorgeirsson","year":"2010","unstructured":"Thorgeirsson TE et al (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42:448\u2013453","journal-title":"Nat Genet"},{"key":"9_CR89","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/ntr\/ntp064","volume":"11","author":"TB Baker","year":"2009","unstructured":"Baker TB et al (2009) Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res Off J Soc Res Nicotine Tob 11:785\u2013796","journal-title":"Nicotine Tob Res Off J Soc Res Nicotine Tob"},{"key":"9_CR90","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/hmg\/ddp216","volume":"18","author":"RM Freathy","year":"2009","unstructured":"Freathy RM et al (2009) A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum Mol Genet 18:2922\u20132927","journal-title":"Hum Mol Genet"},{"key":"9_CR91","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/mp.2015.102","volume":"21","author":"EC Nelson","year":"2016","unstructured":"Nelson EC et al (2016) Evidence of CNIH3 involvement in opioid dependence. Mol Psychiatry 21:608\u2013614","journal-title":"Mol Psychiatry"},{"key":"9_CR92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/mp.2012.164","volume":"19","author":"D Nishizawa","year":"2014","unstructured":"Nishizawa D et al (2014) Genome-wide association study identifies a potent locus associated with human opioid sensitivity. Mol Psychiatry 19:55\u201362","journal-title":"Mol Psychiatry"},{"key":"9_CR93","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/383283","volume":"74","author":"HJ Edenberg","year":"2004","unstructured":"Edenberg HJ et al (2004) Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 74:705\u2013714","journal-title":"Am J Hum Genet"},{"key":"9_CR94","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/hmg\/ddh194","volume":"13","author":"JC Wang","year":"2004","unstructured":"Wang JC et al (2004) Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 13:1903\u20131911","journal-title":"Hum Mol Genet"},{"key":"9_CR95","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C et al (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 95:9608\u20139613","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR96","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/pgs.13.57","volume":"14","author":"BS Haerian","year":"2013","unstructured":"Haerian BS, Haerian MS (2013) OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics 14:813\u2013824","journal-title":"Pharmacogenomics"},{"key":"9_CR97","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1142\/S0219635207001635","volume":"6","author":"S Kapur","year":"2007","unstructured":"Kapur S, Sharad S, Singh RA, Gupta AK (2007) A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. J Integr Neurosci 6:511\u2013522","journal-title":"J Integr Neurosci"},{"key":"9_CR98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1142\/S0219635212500082","volume":"11","author":"D Nagaya","year":"2012","unstructured":"Nagaya D, Ramanathan S, Ravichandran M, Navaratnam V (2012) A118G mu opioid receptor polymorphism among drug addicts in Malaysia. J Integr Neurosci 11:117\u2013122","journal-title":"J Integr Neurosci"},{"key":"9_CR99","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","volume":"13","author":"H Zhang","year":"2008","unstructured":"Zhang H, Kranzler HR, Yang B-Z, Luo X, Gelernter J (2008) The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13:531\u2013543","journal-title":"Mol Psychiatry"},{"key":"9_CR100","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/npp.2013.99","volume":"38","author":"RC Crist","year":"2013","unstructured":"Crist RC et al (2013) An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 38:2003\u20132010","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"9_CR101","first-page":"303","volume":"14","author":"T-K Clarke","year":"2014","unstructured":"Clarke T-K et al (2014) Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. Pharm J 14:303\u2013308","journal-title":"Pharm J"},{"key":"9_CR102","doi-asserted-by":"crossref","first-page":"e75359","DOI":"10.1371\/journal.pone.0075359","volume":"8","author":"B Beer","year":"2013","unstructured":"Beer B et al (2013) Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. PLoS One 8:e75359","journal-title":"PLoS One"},{"key":"9_CR103","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","volume":"7","author":"O Levran","year":"2008","unstructured":"Levran O et al (2008a) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7:720\u2013729","journal-title":"Genes Brain Behav"},{"key":"9_CR104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1369-1600.2012.00445.x","volume":"19","author":"EC Nelson","year":"2014","unstructured":"Nelson EC et al (2014) Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addict Biol 19:111\u2013121","journal-title":"Addict Biol"},{"key":"9_CR105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajmg.b.30510","volume":"144B","author":"G Gerra","year":"2007","unstructured":"Gerra G et al (2007) Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 144B:771\u2013775","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR106","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","volume":"14","author":"V Yuferov","year":"2004","unstructured":"Yuferov V et al (2004) Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics 14:793\u2013804","journal-title":"Pharmacogenetics"},{"key":"9_CR107","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1749-6632.2009.05275.x","volume":"1187","author":"V Yuferov","year":"2010","unstructured":"Yuferov V, Levran O, Proudnikov D, Nielsen DA, Kreek MJ (2010) Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci 1187:184\u2013207","journal-title":"Ann N Y Acad Sci"},{"key":"9_CR108","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ajmg.b.30531","volume":"144B","author":"X Xuei","year":"2007","unstructured":"Xuei X et al (2007) The opioid system in alcohol and drug dependence: family-based association study. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 144B:877\u2013884","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR109","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1601-183X.2012.00785.x","volume":"11","author":"T-K Clarke","year":"2012","unstructured":"Clarke T-K et al (2012) Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav 11:415\u2013423","journal-title":"Genes Brain Behav"},{"key":"9_CR110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1601-183X.2009.00501.x","volume":"8","author":"O Levran","year":"2009","unstructured":"Levran O et al (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531\u2013540","journal-title":"Genes Brain Behav"},{"key":"9_CR111","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/mp.2012.140","volume":"18","author":"MM Jacobs","year":"2013","unstructured":"Jacobs MM et al (2013) Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Mol Psychiatry 18:1205\u20131210","journal-title":"Mol Psychiatry"},{"key":"9_CR112","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10899-007-9060-x","volume":"23","author":"DS Silva Lobo da","year":"2007","unstructured":"da Silva Lobo DS et al (2007) Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 23:421\u2013433","journal-title":"J Gambl Stud"},{"key":"9_CR113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mp.4000207","volume":"2","author":"DE Comings","year":"1997","unstructured":"Comings DE et al (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2:44\u201356","journal-title":"Mol Psychiatry"},{"key":"9_CR114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2009.08.004","volume":"464","author":"Q-F Hou","year":"2009","unstructured":"Hou Q-F, Li S-B (2009) Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci Lett 464:127\u2013130","journal-title":"Neurosci Lett"},{"key":"9_CR115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/mp.2014.113","volume":"20","author":"DSS Lobo","year":"2015","unstructured":"Lobo DSS et al (2015) Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models. Mol Psychiatry 20:1002\u20131010","journal-title":"Mol Psychiatry"},{"key":"9_CR116","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neulet.2013.02.049","volume":"541","author":"X Xie","year":"2013","unstructured":"Xie X et al (2013) Positive association between--1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users. Neurosci Lett 541:258\u2013262","journal-title":"Neurosci Lett"},{"key":"9_CR117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajmg.b.32128","volume":"162B","author":"J Cao","year":"2013","unstructured":"Cao J, LaRocque E, Li D (2013) Associations of the 5-hydroxytryptamine (serotonin) receptor 1B gene (HTR1B) with alcohol, cocaine, and heroin abuse. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 162B:169\u2013176","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR118","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2011.07.114","volume":"412","author":"F Gao","year":"2011","unstructured":"Gao F, Zhu YS, Wei SG, Li SB, Lai JH (2011) Polymorphism G861C of 5-HT receptor subtype 1B is associated with heroin dependence in Han Chinese. Biochem Biophys Res Commun 412:450\u2013453","journal-title":"Biochem Biophys Res Commun"},{"key":"9_CR119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajmg.b.20111","volume":"126B","author":"G Gerra","year":"2004","unstructured":"Gerra G et al (2004) Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 126B:37\u201342","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.pnpbp.2007.12.005","volume":"32","author":"PA Saiz","year":"2008","unstructured":"Saiz PA et al (2008) Association study between obsessive-compulsive disorder and serotonergic candidate genes. Prog Neuro-Psychopharmacol Biol Psychiatry 32:765\u2013770","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9_CR121","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s12031-012-9846-x","volume":"49","author":"D Wilson","year":"2013","unstructured":"Wilson D, da Silva Lobo DS, Tavares H, Gentil V, Vallada H (2013) Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci MN 49:550\u2013553","journal-title":"J Mol Neurosci MN"},{"key":"9_CR122","doi-asserted-by":"crossref","first-page":"e70817","DOI":"10.1371\/journal.pone.0070817","volume":"8","author":"B Zhao","year":"2013","unstructured":"Zhao B et al (2013) Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction. PLoS One 8:e70817","journal-title":"PLoS One"},{"key":"9_CR123","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neulet.2016.08.025","volume":"631","author":"X Xie","year":"2016","unstructured":"Xie X et al (2016) Association between genetic variations of NMDA receptor NR3 subfamily genes and heroin addiction in male Han Chinese. Neurosci Lett 631:122\u2013125","journal-title":"Neurosci Lett"},{"key":"9_CR124","first-page":"349","volume":"3","author":"S-K Lin","year":"2003","unstructured":"Lin S-K, Chen C-K, Ball D, Liu H-C, Loh E-W (2003) Gender-specific contribution of the GABA(A) subunit genes on 5q33 in methamphetamine use disorder. Pharm J 3:349\u2013355","journal-title":"Pharm J"},{"key":"9_CR125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10519-006-9069-4","volume":"36","author":"A Agrawal","year":"2006","unstructured":"Agrawal A et al (2006) Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample. Behav Genet 36:640\u2013650","journal-title":"Behav Genet"},{"key":"9_CR126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajmg.b.30091","volume":"129B","author":"J Covault","year":"2004","unstructured":"Covault J, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR (2004) Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 129B:104\u2013109","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.ypg.0000185027.89816.d9","volume":"16","author":"C Fehr","year":"2006","unstructured":"Fehr C et al (2006) Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatr Genet 16:9\u201317","journal-title":"Psychiatr Genet"},{"key":"9_CR128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpsychires.2006.11.006","volume":"42","author":"M Soyka","year":"2008","unstructured":"Soyka M et al (2008) GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence. J Psychiatr Res 42:184\u2013191","journal-title":"J Psychiatr Res"},{"key":"9_CR129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biopsych.2009.08.019","volume":"67","author":"M-A Enoch","year":"2010","unstructured":"Enoch M-A et al (2010) The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biol Psychiatry 67:20\u201327","journal-title":"Biol Psychiatry"},{"key":"9_CR130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pnpbp.2015.08.003","volume":"64","author":"O Levran","year":"2016","unstructured":"Levran O et al (2016) Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry. Prog Neuro-Psychopharmacol Biol Psychiatry 64:118\u2013123","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9_CR131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2012.04.112","volume":"422","author":"W Wu","year":"2012","unstructured":"Wu W, Zhu YS, Li SB (2012) Polymorphisms in the glutamate decarboxylase 1 gene associated with heroin dependence. Biochem Biophys Res Commun 422:91\u201396","journal-title":"Biochem Biophys Res Commun"},{"key":"9_CR132","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biopsych.2008.04.018","volume":"64","author":"RA Grucza","year":"2008","unstructured":"Grucza RA et al (2008) A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol Psychiatry 64:922\u2013929","journal-title":"Biol Psychiatry"},{"key":"9_CR133","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.572","volume":"42","author":"JZ Liu","year":"2010","unstructured":"Liu JZ et al (2010b) Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42:436\u2013440","journal-title":"Nat Genet"},{"key":"9_CR134","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molbrainres.2005.07.008","volume":"140","author":"C-Y Cheng","year":"2005","unstructured":"Cheng C-Y et al (2005) Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res 140:86\u201390","journal-title":"Brain Res Mol Brain Res"},{"key":"9_CR135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2010.07.022","volume":"1353","author":"H Hou","year":"2010","unstructured":"Hou H et al (2010) Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res 1353:245\u2013248","journal-title":"Brain Res"},{"key":"9_CR136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neulet.2011.03.072","volume":"495","author":"W Jia","year":"2011","unstructured":"Jia W et al (2011) Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence. Neurosci Lett 495:221\u2013224","journal-title":"Neurosci Lett"},{"key":"9_CR137","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.psyneuen.2014.03.017","volume":"45","author":"O Levran","year":"2014","unstructured":"Levran O et al (2014a) Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype. Psychoneuroendocrinology 45:67\u201376","journal-title":"Psychoneuroendocrinology"},{"key":"9_CR138","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/ahg.12064","volume":"78","author":"O Levran","year":"2014","unstructured":"Levran O et al (2014b) Drug addiction and stress-response genetic variability: association study in African Americans. Ann Hum Genet 78:290\u2013298","journal-title":"Ann Hum Genet"},{"key":"9_CR139","first-page":"319","volume":"12","author":"O Levran","year":"2012","unstructured":"Levran O et al (2012) Nerve growth factor beta polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. Pharm J 12:319\u2013327","journal-title":"Pharm J"},{"key":"9_CR140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","volume":"80","author":"S Crettol","year":"2006","unstructured":"Crettol S et al (2006) ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clin Pharmacol Ther 80:668\u2013681","journal-title":"Clin Pharmacol Ther"},{"key":"9_CR141","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/ddn122","volume":"17","author":"O Levran","year":"2008","unstructured":"Levran O et al (2008b) ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet 17:2219\u20132227","journal-title":"Hum Mol Genet"},{"key":"9_CR142","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/mp.2011.124","volume":"17","author":"LJ Bierut","year":"2012","unstructured":"Bierut LJ et al (2012) ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol Psychiatry 17:445\u2013450","journal-title":"Mol Psychiatry"},{"key":"9_CR143","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/302540","volume":"65","author":"CC Chen","year":"1999","unstructured":"Chen CC et al (1999) Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am J Hum Genet 65:795\u2013807","journal-title":"Am J Hum Genet"},{"key":"9_CR144","first-page":"5","volume":"30","author":"HJ Edenberg","year":"2007","unstructured":"Edenberg HJ (2007) The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health J Natl Inst Alcohol Abuse Alcohol 30:5\u201313","journal-title":"Alcohol Res Health J Natl Inst Alcohol Abuse Alcohol"},{"key":"9_CR145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1369-1600.2011.00395.x","volume":"17","author":"J Frank","year":"2012","unstructured":"Frank J et\u00a0al (2012) Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol 17:171\u2013180","journal-title":"Addict Biol"},{"key":"9_CR146","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/mp.2013.145","volume":"19","author":"J Gelernter","year":"2014","unstructured":"Gelernter J et\u00a0al (2014a) Genome-wide association study of alcohol dependence: significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry 19:41\u201349","journal-title":"Mol Psychiatry"},{"key":"9_CR147","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1037\/0033-2909.132.4.607","volume":"132","author":"SE Luczak","year":"2006","unstructured":"Luczak SE, Glatt SJ, Wall TL (2006) Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians. Psychol Bull 132:607\u2013621","journal-title":"Psychol Bull"},{"key":"9_CR148","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00439-013-1281-8","volume":"132","author":"BL Park","year":"2013","unstructured":"Park BL et al (2013) Extended genetic effects of ADH cluster genes on the risk of alcohol dependence: from GWAS to replication. Hum Genet 132:657\u2013668","journal-title":"Hum Genet"},{"key":"9_CR149","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/344287","volume":"71","author":"JB Whitfield","year":"2002","unstructured":"Whitfield JB (2002) Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. Am J Hum Genet 71:1247\u20131250.; author reply 1250\u20131251","journal-title":"Am J Hum Genet"},{"key":"9_CR150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2011.06.008","volume":"120","author":"T-Y Wang","year":"2012","unstructured":"Wang T-Y et al (2012) The aldehyde dehydrogenase 2 gene is associated with heroin dependence. Drug Alcohol Depend 120:220\u2013224","journal-title":"Drug Alcohol Depend"},{"key":"9_CR151","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pnpbp.2012.12.011","volume":"43","author":"T-Y Wang","year":"2013","unstructured":"Wang T-Y et al (2013) The ADH1B and DRD2 gene polymorphism may modify the protective effect of the ALDH2 gene against heroin dependence. Prog Neuro-Psychopharmacol Biol Psychiatry 43:134\u2013139","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9_CR152","first-page":"677","volume":"48","author":"HR Thomasson","year":"1991","unstructured":"Thomasson HR et al (1991) Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet 48:677\u2013681","journal-title":"Am J Hum Genet"},{"key":"9_CR153","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1601-183X.2006.00237.x","volume":"6","author":"M Ikeda","year":"2007","unstructured":"Ikeda M et al (2007) Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav 6:107\u2013112","journal-title":"Genes Brain Behav"},{"key":"9_CR154","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145705005481","volume":"9","author":"M Ikeda","year":"2006","unstructured":"Ikeda M et al (2006) Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. Int J Neuropsychopharmacol 9:77\u201381","journal-title":"Int J Neuropsychopharmacol"},{"key":"9_CR155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biopsych.2013.08.034","volume":"76","author":"J Gelernter","year":"2014","unstructured":"Gelernter J et\u00a0al (2014b) Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry 76:66\u201374","journal-title":"Biol Psychiatry"},{"key":"9_CR156","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12031-013-0186-2","volume":"53","author":"Y Wang","year":"2014","unstructured":"Wang Y et al (2014) A population-based association study of casein kinase 1 epsilon loci with heroin dependence in Han Chinese. J Mol Neurosci MN 53:143\u2013149","journal-title":"J Mol Neurosci MN"},{"key":"9_CR157","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","volume":"78","author":"S Crettol","year":"2005","unstructured":"Crettol S et al (2005) Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther 78:593\u2013604","journal-title":"Clin Pharmacol Ther"},{"key":"9_CR158","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1369-1600.2011.00349.x","volume":"18","author":"O Levran","year":"2013","unstructured":"Levran O et al (2013) CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Addict Biol 18:709\u2013716","journal-title":"Addict Biol"},{"key":"9_CR159","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI60390","volume":"122","author":"MJ Kreek","year":"2012","unstructured":"Kreek MJ et al (2012) Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 122:3387\u20133393","journal-title":"J Clin Invest"},{"key":"9_CR160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopsych.2007.03.019","volume":"63","author":"M Kishimoto","year":"2008","unstructured":"Kishimoto M et al (2008) The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 63:191\u2013196","journal-title":"Biol Psychiatry"},{"key":"9_CR161","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mp.2013.99","volume":"19","author":"J Gelernter","year":"2014","unstructured":"Gelernter J et\u00a0al (2014c) Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry 19:717\u2013723","journal-title":"Mol Psychiatry"},{"key":"9_CR162","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.b.30189","volume":"136B","author":"J Gelernter","year":"2005","unstructured":"Gelernter J et\u00a0al (2005) Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 136B:45\u201352","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR163","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ajmg.b.30565","volume":"147B","author":"Y Morita","year":"2008","unstructured":"Morita Y et al (2008) The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 147B:54\u201358","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR164","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30164","volume":"135B","author":"T Hashimoto","year":"2005","unstructured":"Hashimoto T et al (2005) A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 135B:5\u20139","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"9_CR165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1155\/2012\/651707","volume":"33","author":"CP Morris","year":"2012","unstructured":"Morris CP et al (2012) KPNA3 variation is associated with schizophrenia, major depression, opiate dependence and alcohol dependence. Dis Markers 33:163\u2013170","journal-title":"Dis Markers"},{"key":"9_CR166","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.mp.4002147","volume":"13","author":"DA Nielsen","year":"2008","unstructured":"Nielsen DA et al (2008) Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry 13:417\u2013428","journal-title":"Mol Psychiatry"},{"key":"9_CR167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jamapsychiatry.2013.282","volume":"70","author":"EC Nelson","year":"2013","unstructured":"Nelson EC et al (2013) ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. JAMA Psychiat 70:325\u2013333","journal-title":"JAMA Psychiat"},{"key":"9_CR168","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1038\/tp.2015.158","volume":"5","author":"N Fernandez-Castillo","year":"2015","unstructured":"Fernandez-Castillo N et al (2015) Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence. Transl Psychiatry 5:e667","journal-title":"Transl Psychiatry"},{"key":"9_CR169","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/ajp.2007.164.7.1105","volume":"164","author":"D Matsuzawa","year":"2007","unstructured":"Matsuzawa D et al (2007) Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry 164:1105\u20131114","journal-title":"Am J Psychiatry"},{"key":"9_CR170","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1530-0277.2006.00215.x","volume":"30","author":"N Aoyama","year":"2006","unstructured":"Aoyama N et al (2006) Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin Exp Res 30:1644\u20131649","journal-title":"Alcohol Clin Exp Res"},{"key":"9_CR171","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1196\/annals.1316.040","volume":"1025","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi H et al (2004) Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis\/dependence. Ann N Y Acad Sci 1025:325\u2013334","journal-title":"Ann N Y Acad Sci"},{"key":"9_CR172","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1369-1600.2012.00463.x","volume":"18","author":"PA Lind","year":"2013","unstructured":"Lind PA et al (2013) Genome-wide association study of a quantitative disordered gambling trait. Addict Biol 18:511\u2013522","journal-title":"Addict Biol"}],"container-title":["Advances in Experimental Medicine and Biology","Substance and Non-substance Addiction"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-5562-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T06:27:42Z","timestamp":1512973662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-5562-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811055614","9789811055621"],"references-count":172,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-5562-1_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}